Remdesivir rate volatility leads to insurance claim rejections

Huge variations in the prices of Remdesivir — a crucial drug in the treatment of severe cases of Covid — have resulted in a large increase in insurance claim rejections and also black-listing of hospitals by insurance companies.



April 15, 2021 at 08:15AM